Project Grant HT94252410844
Award Date
8/5/24
Completion Date
8/4/28
Dollars Obligated
$4M
Federal Agency
Defense Health Agency
Awardee
Medcura, Inc. (HFL9S8BZK9N5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Riverdale, MD 20737, USA
Similar Awards
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...
The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
The Department of the Army Medical Command awarded a $993,366 Project Grant to Augusta University Research Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to modulate hemostasis and metabolic homeostasis in order to treat hemorrhagic shock. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development program seeks to improve military and...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,540,000.00 to Colorado State University to develop a Multifunctional Medical Foam (MF) to enhance acute wound management in situ. The 3-year award, starting on March 1, 2025 and ending on February 29, 2028, will support research and development efforts at Colorado State University's Sponsored Programs division to create an innovative medical foam...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $385,536.00 to Epicentrx Inc. to develop and translate a multimodal therapeutic agent and medical countermeasure for the treatment of military-related toxic exposures. The award period is from September 1, 2024 to August 31, 2027. The primary research focus is on creating innovative solutions to address health challenges relevant to military personnel,...
The University of Maryland, Baltimore received a $308,821 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund the development of a novel medical device called the TRANSESOPHAGEAL AORTIC BLOOD FLOW OCCLUDER to control non-compressible torso hemorrhage from January 15, 2022 to January 14, 2024. The device aims to transform trauma care for service members and the public through innovative...
The U.S. Department of Defense's Defense Health Agency has awarded a $902,109 Project Grant to North Carolina State University (NC State) under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," supports the development of advanced nanoparticle-based technologies to improve hemorrhage control at the point of injury. The award period runs from July 1, 2024 to...
The federal Project Grant award, ID HT94252510041, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $582,000 grant was awarded on February 15, 2025 to Nushores Biosciences LLC, a for-profit limited liability company located in Little Rock, Arkansas, to develop an "Electrolysis Assisted Catalytic Oxygen Gas Generator for Battlefield Use". The award has an ultimate completion date of August 14, 2026. The Military...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and...